4-((3,4-DIMETHYLPHENYL)AMINO)-7-(PYRIDIN-4-YL)QUINOLINE-3-CARBOXAMIDE, 95%, 25mg

Methyl 5,6-dichloropicolinate, 97%, 1g

2-Methoxyethanol, min. 99 %, zur Synthese, 2.5 l, Glasverpackung

OXAZOLO[5,4-C]PYRIDIN-2(1H)-ONE, HEXAHYDRO-, HCL, 95.0%, 100mg

Atipamezole, 98%, 1g

CYCLOBUTANE-1,2-DICARBOXYLIC ACID, 95.0%, 5g

5-Fluoro-1-(2-fluorobenzyl)-3-iodo-1H-pyrazolo[3,4-b]pyridine, 95.0%, 1g

(2-methylpropyl)(2-phenylpropyl)amine, 95.0%, 1g

Ethyl 5-bromothieno[2,3-c]pyridine-2-carboxylate, 97%, 100mg

((2R,5R)-5-METHYLPIPERAZIN-2-YL)METHANOL HCL, 95.0%, 1g

(R)-2-(2-(((9H-FLUOREN-9-YL)METHOXY)CARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLIN-3-YL)ACETIC ACID, 95%, 1g

4-Hydrazinylpyrimidine, 95.0%, 5g

Nizatidine, 98%, 250mg